BioInfra Co., Ltd. (KOSDAQ:199730)

South Korea flag South Korea · Delayed Price · Currency is KRW
5,640.00
-10.00 (-0.18%)
At close: Aug 13, 2025, 3:30 PM KST
-28.52%
Market Cap 27.44B
Revenue (ttm) 24.25B
Net Income (ttm) -4.24B
Shares Out 4.86M
EPS (ttm) -871.09
PE Ratio n/a
Forward PE n/a
Dividend 400.00 (7.09%)
Ex-Dividend Date Dec 27, 2024
Volume 3,987
Average Volume 24,294
Open 5,680.00
Previous Close 5,650.00
Day's Range 5,560.00 - 5,680.00
52-Week Range 4,965.00 - 11,580.00
Beta 0.84
RSI 52.00
Earnings Date n/a

About BioInfra

Bioinfra Co., Ltd. operates as a contract research organization for phase 1 clinical trials. Its primary product is a bioequivalence test for generic drugs, a phase 1 test for incrementally modified drugs; and a phase 1 sample analysis for other new substances. The company was founded in 2007 and is based in Yongin-si, South Korea. [Read more]

Industry Commercial Physical and Biological Research
Founded 2007
Country South Korea
Stock Exchange KOSDAQ
Ticker Symbol 199730
Full Company Profile

Financial Performance

Financial Statements

News

There is no news available yet.